Syndax Pharmaceuticals
SNDX
SNDX
217 hedge funds and large institutions have $953M invested in Syndax Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 86 increasing their positions, 67 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
217
Holders Change
-1
Holders Change %
-0.46%
% of All Funds
2.91%
Holding in Top 10
7
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-30%
% of All Funds
0.09%
New
31
Increased
86
Reduced
67
Closed
30
Calls
$14.4M
Puts
$12.5M
Net Calls
+$1.84M
Net Calls Change
-$8.34M
Top Buyers
| 1 |
BlackRock
New York
|
+$17.9M |
| 2 |
Goldman Sachs
New York
|
+$17.6M |
| 3 |
Millennium Management
New York
|
+$11M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$9.06M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$7.78M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$21.3M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$17.6M |
| 3 |
TIM
Thornburg Investment Management
Santa Fe,
New Mexico
|
-$16.1M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$15.8M |
| 5 |
Morgan Stanley
New York
|
-$13.4M |
